Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PLUR
stocks logo

PLUR

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Valuation Metrics

The current forward P/E ratio for Pluri Inc (PLUR.O) is -0.28, compared to its 5-year average forward P/E of -1.81. For a more detailed relative valuation and DCF analysis to assess Pluri Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.81
Current PE
-0.28
Overvalued PE
0.40
Undervalued PE
-4.02

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.63
Current PS
0.00
Overvalued PS
8.75
Undervalued PS
-5.48

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

PLUR News & Events

Events Timeline

(ET)
2025-05-15
07:16:53
Pluri CEO issues letter to shareholders
select
2025-04-28 (ET)
2025-04-28
08:22:26
Pluri completes strategic acquisition of 71% of equity of Kokomodo for $4.5M
select
2025-04-10 (ET)
2025-04-10
08:34:24
Pluri announces USPTO issued patent covering its immune cell expansion tech
select
Sign Up For More Events
Sign Up For More Events

News

Preview
4.5
05-15Newsfilter
Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion

  • Company Growth and Market Expansion: Pluri Inc. reported a nearly 400% revenue growth in the first nine months of fiscal year 2025, driven by advancements in its CDMO and AgTech businesses, as well as new partnerships in cultivated cacao and coffee markets.

  • Technological Innovations and Strategic Partnerships: The company is leveraging its proprietary cell expansion technology to produce sustainable food products and has secured additional investments to enhance its operations, while also addressing challenges in healthcare and agriculture sectors.

Preview
3.5
04-10Newsfilter
Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel

  • Pluri's Patents and MAIT Cell Therapy: Pluri Inc. has been granted patents for its immune cell expansion technologies, particularly focusing on Mucosal-Associated Invariant T (MAIT) cells, which are promising for treating solid tumors and have the potential to revolutionize cancer immunotherapy.

  • Innovative 3D Cell Expansion Technology: The company utilizes a proprietary 3D cell expansion technology that mimics the natural environment of immune cells, allowing for efficient large-scale production of MAIT cells, which could lead to "off-the-shelf" therapies for cancer patients.

Preview
8.5
01-23Business Insider
Pluri Secures $6.5 Mln Investment To Buy 71% Of Kokomodo To Enter Cocao Market

  • Investment and Acquisition: Pluri Inc. announced a $6.5 million private investment led by Alejandro Weinstein, while concurrently acquiring a 71% stake in Kokomodo Ltd. for $4.5 million, to be paid in shares.

  • Strategic Goals: The company aims to enhance its financial position and expand into the cultivated cacao market through this acquisition, which is expected to close in the second quarter of 2025.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Pluri Inc (PLUR) stock price today?

The current price of PLUR is 5.28 USD — it has increased 4.76 % in the last trading day.

arrow icon

What is Pluri Inc (PLUR)'s business?

Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.

arrow icon

What is the price predicton of PLUR Stock?

Wall Street analysts forecast PLUR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PLUR is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Pluri Inc (PLUR)'s revenue for the last quarter?

Pluri Inc revenue for the last quarter amounts to 427.00K USD, increased 501.41 % YoY.

arrow icon

What is Pluri Inc (PLUR)'s earnings per share (EPS) for the last quarter?

Pluri Inc. EPS for the last quarter amounts to -0.94 USD, increased 9300.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Pluri Inc (PLUR)'s fundamentals?

The market is revising No Change the revenue expectations for PLUR for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 17.47%.
arrow icon

How many employees does Pluri Inc (PLUR). have?

Pluri Inc (PLUR) has 123 emplpoyees as of May 17 2025.

arrow icon

What is Pluri Inc (PLUR) market cap?

Today PLUR has the market capitalization of 40.81M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free